How Are Most Drugs Excreted From the Body?

Most drugs leave your body through your kidneys, filtered from the blood and flushed out in urine. The kidneys handle the bulk of drug elimination for the majority of medications on the market, but they are not the only exit route. The liver pushes certain drugs into bile and out through feces, and smaller amounts escape through the lungs, sweat, saliva, and even breast milk. How efficiently any of these routes works depends on the drug’s chemistry, your age, your kidney health, and what other medications you are taking.

Why the Kidneys Do Most of the Work

Your kidneys filter roughly a tenth of your blood volume at the glomerulus every pass, driven by arterial blood pressure. That constant, high-volume filtration makes them ideally suited for clearing water-soluble waste, including drugs and their breakdown products. Only the portion of a drug that floats freely in the blood, unattached to plasma proteins, gets pushed through the filter. So a drug that binds tightly to proteins in the blood tends to stay in circulation longer, while one that circulates mostly unbound gets filtered out more readily.¹

Filtration alone does not tell the whole story, though. The kidney’s proximal tubule, the stretch of tubing just downstream of the filter, is packed with specialized transporter proteins that actively pump drugs from the blood into the urine. This process, called tubular secretion, can clear drugs far faster than passive filtration alone because the transporters grab compounds that filtration missed, including some still bound to proteins. Different transporter families handle positively charged molecules versus negatively charged ones, which is why two drugs with similar sizes can have wildly different excretion rates depending on their electrical charge.² The proximal tubule is effectively the kidney’s heavy-lifter for actively clearing a wide variety of drug types, from pain medications to antibiotics.³

Why Some Drugs Get Pulled Back In

Not everything that enters the tubule makes it to the bladder. As urine flows through the kidney’s long tubular network, water is steadily reabsorbed, concentrating whatever remains inside. Drugs that are fat-soluble enough to cross cell membranes can slip back through the tubule wall and re-enter the bloodstream, a process called tubular reabsorption. The more lipophilic (fat-loving) a drug is, the more readily it gets reabsorbed, which slows its elimination and extends its stay in your body.⁴

This is one reason many drugs need to be chemically modified by the liver before they can be eliminated. The liver’s enzymes attach water-friendly chemical groups to fat-soluble drugs, converting them into metabolites that are less likely to be reabsorbed in the kidney tubule. Without that metabolic step, a fat-soluble drug would cycle endlessly between filtration and reabsorption, never fully leaving the body. The interplay between the liver’s metabolic conversion and the kidney’s filtration is what ultimately determines how quickly most drugs disappear from your system.

How Urine Chemistry Affects Drug Excretion

Whether a drug molecule carries a charge in the tubular fluid depends partly on the pH of the urine. Weak acids lose a proton and become charged in alkaline urine, which traps them in the tubule because charged molecules cannot easily cross the cell membrane to be reabsorbed. Weak bases behave the opposite way, becoming trapped in acidic urine. This principle has real clinical uses. In a phenobarbital overdose, for instance, doctors sometimes infuse sodium bicarbonate to make the urine more alkaline. In one documented case, alkalinizing the urine to a pH of about 8.5 boosted the concentration of phenobarbital in urine from 37 micrograms per milliliter to over 200 micrograms per milliliter in under nine hours.⁵

That said, urinary alkalinization is not a universal antidote. Even in the phenobarbital case, the overall elimination half-life did not clearly shorten despite the surge in urinary drug concentration. The technique works best for a narrow class of drugs: weak acids with long half-lives that are already heavily dependent on kidney excretion. For most overdoses involving different drug types, other strategies like activated charcoal or dialysis are more appropriate.

The Biliary Route and Enterohepatic Recycling

For drugs that the kidneys cannot handle efficiently, especially large, bulky molecules and those that are heavily metabolized in the liver, the biliary pathway serves as a second major exit. The liver takes up these drugs, processes them, and pumps them into bile through a set of dedicated transporter proteins on the surface of liver cells facing the bile ducts.⁶ From there, bile carries the drug into the small intestine, and if it is not reabsorbed, it exits in feces.

But many drugs that enter the gut via bile do get reabsorbed, creating a loop called enterohepatic recycling. The liver conjugates a drug to make it water-soluble, ships it into the intestine via bile, and then gut bacteria break off the conjugate, regenerating the original fat-soluble drug, which crosses the intestinal wall and returns to the bloodstream. This recycling can significantly extend a drug’s presence in the body and is often the reason you see a secondary spike in blood levels hours after the first peak.⁷

The gut microbiome plays a surprisingly active role here. Bacteria in the intestine produce enzymes that reverse the liver’s metabolic work, freeing drug molecules for reabsorption. This is not always harmless. With some chemotherapy drugs and anti-inflammatory medications, bacterial re-activation increases exposure to toxic metabolites, contributing to side effects like intestinal damage.⁸ Anything that disrupts your gut bacteria, from antibiotics to dietary changes, can alter how much of a recycled drug you are actually exposed to.

Minor Exit Routes That Still Matter

Beyond the kidneys and liver, several other tissues act as smaller-scale excretion pathways. Volatile drugs and anesthetics provide the clearest example. Inhaled anesthetics are designed to enter and leave through the lungs, and their elimination depends almost entirely on breathing them out. Because these agents tend to be poorly water-soluble, the kidneys are essentially useless for clearing them. Instead, metabolism in the liver is the only alternative clearance pathway while the drug remains in the body, and whatever is not metabolized gets exhaled.

Sweat and saliva carry trace amounts of many drugs. Researchers have detected drugs and their metabolites in saliva within a couple of hours of dosing, and in sweat with concentrations that can keep rising for a day or more.⁹ These routes do not meaningfully reduce drug levels in the blood, so they are clinically insignificant for elimination. Their real importance is in drug testing: roadside saliva tests and sweat patches exploit these minor excretion paths to detect recent drug use.

Breast milk is a more consequential minor route. Drugs cross into milk based on their fat-solubility, their electrical charge at the milk’s slightly lower pH, and how much they bind to milk proteins versus blood proteins.¹⁰ The quantity reaching the infant through milk is usually small, but for potent drugs or vulnerable newborns, even small amounts can matter. This is why doctors review medication safety for breastfeeding mothers on a drug-by-drug basis rather than issuing blanket approvals.

Hair and nails incorporate drugs as they grow, trapping small quantities of substances in the keratin matrix. This is not excretion in the sense that it removes drugs from circulation; the amounts are negligible for that purpose. But nails and hair offer a forensic archive, recording drug exposure over weeks or months. Nail analysis has been used in postmortem drug detection, workplace testing, and screening for prenatal drug exposure.¹¹ Researchers have explored nails as an alternative to hair for evaluating long-term drug use, since nails are less susceptible to cosmetic contamination from external products.¹²

How Age Changes Drug Excretion

Kidney function is not static across your lifespan, and the swings are dramatic at both ends. Newborns and young infants have immature kidneys with reduced filtration rates, underdeveloped tubular secretion, and limited concentrating ability. For drugs that depend heavily on renal excretion, like the antiepileptic levetiracetam, clearance at birth is slow but ramps up quickly, sometimes doubling within the first week of life. By two to three months of age, infants often clear drugs faster per kilogram of body weight than adults do.¹³ That rapid maturation continues through early childhood, with full adult-level kidney function typically reached by age two.¹⁴

At the other end of life, the kidneys gradually shrink, lose functioning filtration units, and develop thickened blood vessels and scarring. Both the filtration rate and renal blood flow decline with age, which directly slows the elimination of renally excreted drugs.¹⁵ This is a major contributor to drug toxicity in older adults. A dose that is safe for a 30-year-old can accumulate to dangerous levels in an 80-year-old whose kidneys filter at half the rate. Medications like certain antibiotics, heart rhythm drugs, and diabetes medications need dose reductions or longer intervals between doses when kidney function has declined.

Kidney Disease and Dose Adjustment

Chronic kidney disease slows drug clearance in a gradual, somewhat predictable way. As the filtration rate drops, drug levels in the blood rise unless doses are adjusted. The standard clinical approach is to estimate the patient’s kidney function using a blood test and then reduce the dose, lengthen the time between doses, or both.¹⁶ Acute kidney injury is trickier because kidney function can fluctuate day to day, making it harder to predict how quickly a drug will be cleared. Whether kidney disease is acute or chronic, the net effect is the same: drugs hang around longer, and their volume of distribution may shift as well.¹⁷

What surprises many people is that kidney disease also alters the elimination of drugs that are not primarily excreted by the kidneys. The accumulation of waste products in kidney failure can inhibit liver enzymes and drug transporters elsewhere in the body, throwing off the metabolism and clearance of drugs you would not think of as “kidney drugs.” This is why doctors reassess nearly every medication, not just the obviously renally cleared ones, when a patient develops significant kidney impairment.

Drug Interactions at the Kidney Level

When two drugs compete for the same transporter in the kidney tubule, one can block the other’s excretion. These renal drug-drug interactions tend to be subtler than liver-based interactions. The change in blood levels from blocking a kidney transporter is usually less than a twofold increase, which is modest compared to the tenfold or greater swings that can happen when liver enzymes are inhibited.¹⁸ But “modest” does not mean harmless. For drugs with a narrow margin between a therapeutic dose and a toxic one, even a small increase in blood levels can cause problems.

The risk is amplified in people whose kidneys are already compromised. When filtration is reduced, tubular secretion becomes a proportionally larger share of how a drug gets eliminated. Blocking that secretion in someone with low filtration capacity removes a bigger fraction of their remaining clearance than it would in someone with healthy kidneys.¹⁹ Elderly patients and those with diabetes, who often take many medications simultaneously and may already have reduced kidney function, face a disproportionate share of this risk.

Genetic Variation in Drug Transporters

The transporter proteins that shuttle drugs into bile or urine are encoded by genes, and those genes vary from person to person. Genetic differences in transporter expression or function can substantially alter how much of a drug ends up in the blood versus how quickly it gets pumped into the urine or bile.²⁰ Someone carrying a variant that reduces the activity of a kidney uptake transporter will clear that drug more slowly, leading to higher blood levels from the same dose. Conversely, a more active transporter variant could lower drug levels enough to reduce effectiveness.

Clinical studies have connected transporter gene variants to measurable differences in how individual patients handle specific drugs, including altered blood concentrations and heightened risk of side effects.²¹ Sometimes the change happens at the tissue level rather than in the blood. A variant in a transporter at a target organ can raise or lower drug concentrations locally, at the site where the drug actually acts, without changing what a standard blood test would show. This complicates dose optimization and explains some cases where patients experience toxicity despite apparently normal blood levels.

Where Excreted Drugs End Up in the Environment

Every drug you excrete in urine or feces eventually enters the wastewater system, and conventional sewage treatment does not remove all of it. Pharmaceuticals persist in treated wastewater effluent at concentrations high enough to pose measurable ecological risks. Antibiotics in waterways are particularly problematic for algae and small aquatic invertebrates, while compounds like certain antiepileptics and cholesterol-lowering drugs can bioaccumulate in fish.²²

This is not a hypothetical concern. Researchers have detected pharmaceutical residues in rivers, lakes, and drinking water sources worldwide. The widespread use of antibiotics, in particular, has raised alarms about whether sub-lethal drug concentrations in water could accelerate the development of antibiotic-resistant bacteria. Proper drug disposal, like pharmacy take-back programs rather than flushing unused pills, reduces but does not eliminate the issue, because the main source of environmental contamination is the drugs your body has already excreted naturally. Improved wastewater treatment technologies are the more scalable long-term fix, though most municipal systems have not yet adopted them.